Diagnos Laboratorium Utama Tbk. vs Medikaloka Hermina Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Medikaloka Hermina Tbk. trades at Rp715 (market cap 10.83T, 8.01M 24h volume). The key difference: Medikaloka Hermina Tbk. is far larger — about 33.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Medikaloka Hermina Tbk. is more actively traded (8.01M versus 7.6K). Which is the better fit depends on your goals.
| DGNS | HEAL | |
|---|---|---|
Market Cap | 319B | 10.83T |
Volume | 7.6K | 8.01M |
Lot | 76 | 80.09K |
Turnover | 1.74M | 5.6B |
Average Price | 229.21 | 699.78 |
Value | 1.74M | 5.6B |
Indicative Equilibrium Price | 232 | 705 |
Indicative Equilibrium Volume | 200 | 81.6K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Medikaloka Hermina Tbk (“the Company”) was established based on Notarial Deed of Imam Santoso, S.H., No. 5 dated May 7, 1999.
Read more on HEAL →